Search Within

Gary Schwartz

Formats
  1. Journal Article (191)
  2. Meeting Abstract (190)
  3. Conference Paper (3)
  4. Book Section (1)
Groups
  1. Department of Medicine (215)
  2. Solid Tumor Oncology Division (205)
  3. Center for Pancreatic Cancer Research (99)
  4. Gastrointestinal Oncology Service (99)
  5. GSK Faculty (91)
  6. Epidemiology and Biostatistics (69)

More Groups

People
  1. David Kelsen (79)
  2. Richard Carvajal (61)
  3. Manish Shah (41)
  4. Mark Dickson (40)
  5. Eileen O'Reilly (36)
  6. Monica Motwani (36)

More People

Years
  1. 2023 (1)
  2. 2020 (1)
  3. 2018 (2)
  4. 2016 (3)
  5. 2015 (5)
  6. 2014 (23)

More Years

Publications
  1. Journal of Clinical Oncology (103)
  2. Cancer Research (42)
  3. Clinical Cancer Research (39)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (30)
  5. Annals of Oncology (12)
  6. Cancer (12)

More Publications

Publishers
  1. American Association for Cancer Research (121)
  2. American Society of Clinical Oncology (105)
  3. Elsevier Inc. (20)
  4. Springer (20)
  5. Oxford University Press (16)
  6. Wiley Blackwell (15)

More Publishers

Results (385)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multicenter sequential phase II study of flavopiridol plus oxaliplatin (Alvocidib) with or without 5-FU and leucovorin (LV) for patients (pts) with refractory germ cell tumors (GCT) including late relapse (LR)
    Meeting Abstract

    Feldman, D. R.; Stadler, W. M.; Appleman, L. J.; Quinn, D. I.; Costello, B. A.; Schwartz, G. K.; Reuter, V. E.; Woo, K.; Patil, S.; Fusco, A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • The phosphoinositide 3-kinase a selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ/GNA11-mutant uveal melanoma cells
    Journal Article

    Musi, E.; Ambrosini, G.; de Stanchina, E.; Schwartz, G. K.
    Molecular Cancer Therapeutics (2014)

    Fulltext@MSK | Save
  • Clinical cancer advances 2013: Annual report on progress against cancer from the American Society of Clinical Oncology
    Journal Article

    Patel, J. D.; Krilov, L.; Adams, S.; Aghajanian, C.; Basch, E.; Brose, M. S.; Carroll, W. L.; de Lima, M.; Gilbert, M. R.; Kris, M. G.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Romiplostim for management of chemotherapy-induced thrombocytopenia
    Journal Article

    Parameswaran, R.; Lunning, M.; Mantha, S.; Devlin, S.; Hamilton, A.; Schwartz, G.; Soff, G.
    Supportive Care in Cancer (2014)

    Fulltext@MSK | Save
  • Sarcoma immunotherapy: Past approaches and future directions
    Journal Article

    D'Angelo, S. P.; Tap, W. D.; Schwartz, G. K.; Carvajal, R. D.
    Sarcoma (2014)

    Fulltext@MSK | Save
  • Prognostic implication of KIT mutations in melanoma
    Meeting Abstract

    Roth, K. G.; Zabor, E. C.; Colgan, M. N.; Wolchok, J. D.; Chapman, P. B.; Schwartz, G. K.; Panageas, K. S.; Carvajal, R. D.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase Ib/II study of imatinab and everolimus in patients with PDGFRA plus synovial sarcoma
    Meeting Abstract

    Keohan, M. L.; Tap, W. D.; Dickson, M. A.; D'Angelo, S. P.; Carvajal, R. D.; Gounder, M. M.; Morales, R. E.; Condy, M. M.; Hameed, M.; Ho, A. L.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Vemurafenib (VEM) in patients (pts) with BRAF-mutant melanoma and brain metastases (mets)
    Meeting Abstract

    Harding, J. J.; Catalanotti, F.; Yaqubie, A.; McDermott, G. C.; Kersellius, R.; Merghoub, T.; Carvajal, R. D.; D'Angelo, S. P.; Dickson, M. A.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Alliance A091102: Phase II study of MLN8237 (alisertib) in advanced/metastatic sarcoma
    Meeting Abstract

    Dickson, M. A.; Mahoney, M. R.; Marchello, B. I. T.; Condy, M.; Tap, W. D.; Schwartz, G. K.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified liposarcoma
    Meeting Abstract

    Dickson, M. A.; Tap, W. D.; Keohan, M. L.; D'Angelo, S. P.; Gounder, M. M.; Chi, P.; Antonescu, C. R.; Landa, J.; Qin, L. X.; Rathbone, D. D.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save